Page 98 - Read Online

Page 14 of 15 Magnifico et al. Rare Dis Orphan Drugs J 2023;2:16 https://dx.doi.org/10.20517/rdodj.2023.17

Authors’ contributions
Design of the methodology and the search algorithm: Magnifico G, Benvenuti S
Blind selection of the articles: Magnifico G, Artuso I
Writing of the manuscript: Magnifico G, Artuso I, Benvenuti S

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported in part by Regione Lombardia, ITALY [FT5132], and by Fondazione Telethon
[GSP21003].

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2023.

REFERENCES
1. Loeber JG, Platis D, Zetterström RH, et al. Neonatal screening in europe revisited: An ISNS perspective on the current state and
developments since 2010. Int J Neonatal Screen 2021;7:15. DOI PubMed PMC
2. Berg JS, Foreman AK, O'Daniel JM, et al. A semiquantitative metric for evaluating clinical actionability of incidental or secondary
findings from genome-scale sequencing. Genet Med 2016;18:467-75. DOI PubMed PMC
3. Berg JS, Agrawal PB, Bailey DB Jr, et al. Newborn sequencing in genomic medicine and public health. Pediatrics 2017:139. DOI
PubMed PMC
4. Burlina A, Jones SA, Chakrapani A, et al. A new approach to objectively evaluate inherited metabolic diseases for inclusion on
newborn screening programmes. Int J Neonatal Screen 2022;8:25. DOI PubMed PMC
5. Milko LV, O'Daniel JM, DeCristo DM, et al. An age-based framework for evaluating genome-scale sequencing results in newborn
screening. J Pediatr 2019;209:68-76. DOI PubMed PMC
6. Ceyhan-Birsoy O, Machini K, Lebo MS, et al. A curated gene list for reporting results of newborn genomic sequencing. Genet Med
2017;19:809-18. DOI PubMed PMC
7. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria
over the past 40 years. Bull World Health Organ 2008;86:317-9. DOI PubMed PMC
8. Pereira S, Robinson JO, Gutierrez AM, et al; BabySeq Project Group. Perceived benefits, risks, and utility of newborn genomic
sequencing in the babyseq project. Pediatrics 2019;143:S6-S13. DOI PubMed PMC
9. Zacharias RL, Smith ME, King JS. The legal dimensions of genomic sequencing in newborn screening. Hastings Cent Rep 2018;48
Suppl 2:S39-41. DOI PubMed
10. Tarini BA, Goldenberg AJ. Ethical issues with newborn screening in the genomics era. Annu Rev Genomics Hum Genet 2012;13:381-
93. DOI PubMed PMC
11. Lantos JD. Ethical and psychosocial issues in whole genome sequencing (WGS) for newborns. Pediatrics 2019;143:S1-5. DOI
PubMed
12. Ross LF, Clayton EW. Ethical issues in newborn sequencing research: the case study of babyseq. Pediatrics 2019:144. DOI PubMed
PMC
13. Pichini A, Ahmed A, Patch C, et al. Developing a national newborn genomes program: an approach driven by ethics, engagement and
co-design. Front Genet 2022;13:866168. DOI PubMed PMC
14. Holm IA, Agrawal PB, Ceyhan-Birsoy O, et al; BabySeq project team. the babyseq project: implementing genomic sequencing in
newborns. BMC Pediatr 2018;18:225. DOI PubMed PMC
15. Schuijff M, Dijkstra AM. Practices of responsible research and innovation: a review. Sci Eng Ethics 2020;26:533-74. DOI PubMed